Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Immunogenet ; 44(6): 322-327, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28929613

ABSTRACT

To investigate whether 14-bp Ins/Del polymorphism in HLA-G gene is associated with the risk of chronic hepatitis B (CHB) infection. This study was performed on a total of 396 individuals including 199 CHB patients and 197 healthy subjects from a south-east Iranian population. We genotyped 14-bp Ins/Del polymorphism in the HLA-G gene using polymerase chain reaction method. The results of our study revealed that the HLA-G 14-bp deletion polymorphism was associated with a reduced risk of CHB at both allele and genotypic levels. The 14-bp Del allele and Ins/Del genotype were more frequent in control group than in CHB patients (37% vs 28% for Del allele with OR = 0.68 and p-value = .015; 73% vs 52% for Ins/Del genotype with OR = 0.43 and p-value = .001) and both were protective factors against CHB. However, no difference was found in the distribution of HLA-G 14-bp genotypes among subjects with varied levels of HBV DNA or hepatic enzymes (p > .05). Our findings, for the first time, suggest that the HLA-G 14-bp Ins/Del polymorphism may be a marker for genetic susceptibility to CHB infection.


Subject(s)
Base Pairing/genetics , HLA-G Antigens/genetics , Hepatitis B, Chronic/genetics , Hepatitis B, Chronic/prevention & control , Sequence Deletion/genetics , Adolescent , Adult , Alleles , Case-Control Studies , Ethnicity/genetics , Female , Humans , Iran , Male , Middle Aged , Polymorphism, Single Nucleotide/genetics , Young Adult
2.
Epidemiol Infect ; 145(3): 491-497, 2017 02.
Article in English | MEDLINE | ID: mdl-27866494

ABSTRACT

This study assessed the seroprevalence of brucellosis and its risk factors in migratory nomads in the Fars province of Iran. Active brucellosis was defined as the combination of clinical symptoms, including fever, chills, night sweats, headache, low back pain, arthralgia, or myalgia, and positive laboratory testing, including either a serum agglutination test (SAT) ⩾1:80 with a 2-mercaptoethanol (2-ME) test ⩾1:40, or a SAT <1:80 combined with a positive Coombs Wright test (CWT) at a titre of at least threefold higher than SAT titre results. For the 536 participants, the female (316, 59%) to male (220, 41%) ratio was 1·4 and the participants' mean age was 32·4 ± 18·9 (range 1-96) years. Of all participants, 325 (60·6%) showed clinical symptoms; in symptomatic participants, the Rose Bengal plate test was positive in 33 (6·1%) cases, the SAT was positive in 18 (3·3%) cases, and the 2-ME test was positive in 30 (5·5%) cases. Positive SAT and 2-ME results were seen in 18 (3·3%) cases, but a negative SAT and a positive CWT were found in 36 (6·7%) cases. As a result, active brucellosis was detected in 54 cases, indicating a prevalence of 10% (95% confidence interval 8-12). In conclusion, we determined that brucellosis is a prevalent yet neglected disease in this nomadic population. Brucellosis control is not possible as long as these high-risk populations remain neglected.


Subject(s)
Antibodies, Bacterial/blood , Brucellosis/epidemiology , Neglected Diseases/epidemiology , Transients and Migrants , Adolescent , Adult , Aged , Aged, 80 and over , Agglutination Tests , Bacteriological Techniques , Brucellosis/pathology , Child , Child, Preschool , Female , Humans , Infant , Iran/epidemiology , Male , Middle Aged , Neglected Diseases/pathology , Risk Factors , Seroepidemiologic Studies , Young Adult
3.
Hum Exp Toxicol ; 34(7): 744-54, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25392345

ABSTRACT

Administration of natural antioxidants has been used to protect against nephrolithiasis. Urolithiasis was induced by ethylene glycol (EG) in Wistar rats. For 4 weeks, group 1 (control) was fed with a standard commercial diet. Group 2 received the same diet with 0.75% of EG. Group 3 received EG plus the diet and water added with antioxidant nutrients and lime juice as the dietary source of citrate (EG + AX). Group 4 same as group 3 with no EG in water. For 8 weeks, group 5 was fed the standard diet with EG in water for the first 28 days, followed by no EG. Group 6 received the diet with EG for the first 28 days, followed by discontinuation of EG and addition of antioxidant nutrients. Group 7 were provided the diet with antioxidant nutrients for 8 weeks. Group 8 received the diet with antioxidant nutrients for 4 weeks, followed by antioxidant nutrients with EG for the next 4 weeks. Blood samples were collected and kidneys were removed. The size and the mean number of crystal deposits in EG-treated groups was significantly higher than the EG-treated groups, added with antioxidant nutrients and lime juice. After 4 weeks, the mean concentration of malondialdehyde in group 2 was higher than the group 3, and significantly lower in group 4; and in groups 7 after 8 weeks, as well. After 8 weeks, supplementation developed less mean number of deposits in group 6 as compared to group 5; and in group 8, the crystal deposits was substantially less than either group 2 or group 5 (EG-treated rats). Elevated concentration of androgens (as promoters of the formation of renal calculi) as a result of EG consumption decreased following antioxidant supplementations. Results showed a beneficial effect of antioxidant and provided superior renal protection on treating and preventing stone deposition in the rat kidney.


Subject(s)
Antioxidants/pharmacology , Antioxidants/therapeutic use , Nephrolithiasis/drug therapy , Animals , Ascorbic Acid/pharmacology , Ascorbic Acid/therapeutic use , Boron/pharmacology , Boron/therapeutic use , Dihydrotestosterone/blood , Ethylene Glycol , Kidney/drug effects , Kidney/pathology , Malondialdehyde/blood , Nephrolithiasis/blood , Nephrolithiasis/chemically induced , Nephrolithiasis/pathology , Oxidative Stress/drug effects , Rats, Wistar , Selenium/pharmacology , Selenium/therapeutic use , Sex Hormone-Binding Globulin/analysis , Testosterone/blood , Treatment Outcome , Vitamin A/pharmacology , Vitamin A/therapeutic use , Vitamin B 6/pharmacology , Vitamin B 6/therapeutic use , Vitamin E/pharmacology , Vitamin E/therapeutic use , Vitamins/pharmacology , Vitamins/therapeutic use , Zinc/pharmacology , Zinc/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...